230 Users Online
Acute Otitis Media Treatment Market Segmented By drug class such as Antibiotics, Analgesic, Antipyretic, Antihistamines, Decongestant, NSAID’s in Hospital Pharmacies, Retail Pharmacies and Online Pharmacies distribution channel
Acute otitis media is a specific type of ear infection which is very painful. When the eardrum becomes infected and inflamed its results the acute otitis media. Antibiotics are the initial choice of physician for acute otitis media treatment.
Commonly prescribed antibiotics for the acute otitis media treatment are amoxicillin, cefaclor, cefprozil, cefurozime, cefixime, cefpodoxime, cefdinir, and azithromycin. If antibiotic does not work then analgesic and antipyretic drugs are prescribed for the acute otitis media treatment. For a few patients, the physician prescribes the antihistamines and decongestant for the acute otitis media treatment.
If the patient does not respond to any of the medication mentioned above, then the physician prescribes the steroids for the acute otitis media treatment. If the acute otitis media is not curing by the medication therapy then physician prescribes the patient to go for surgical therapy for acute otitis media treatment. There are three types of surgical method for acute otitis media treatment, viz. tympanocentesis, myringotomy, and tympanostomy.
The rising prevalence of ear infections primary factor driving the growth of acute otitis media treatment market throughout the globe. The launch of novel drugs for the acute otitis media treatment by the leading pharmaceutical companies will propel the growth of acute otitis media treatment market. Also, the availability of generic drugs over the branded drugs at a lower price for acute otitis media treatment will propel the growth of acute otitis media treatment.
Stringent guidelines by the various government authorities for the approval of the drug for the acute otitis media treatment among the children may hamper the growth of acute otitis media treatment market over the forecast period. Also, the lack of awareness among the people about the ear infection if under developing economies may also lead to sluggish growth of acute otitis media treatment market.
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
| Based on drug class |
|
| Based on distribution channel |
|
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionNorth America region expected to dominate the Acute Otitis Media Treatment market by revenue share owing high availability of novel drug s for the acute otitis media treatment market in the U.S. and Canada. After North America, Acute Otitis Media Treatment market is then followed by Europe owing to rising patient pool suffering from an ear infection in U.K. Germany, France, and other European countries.
Availability of generic drugs for acute otitis media treatment in India and China is the key factor behind the robust growth of Acute Otitis Media Treatment market in Asia-Pacific. MEA and Latin America is the less attractive segment for Acute Otitis Media Treatment market anticipated to low availability of medical facilities in this region. China, India, Brazil, and Russia are the emerging countries for Acute Otitis Media Treatment market.
Some of the key players found across the value chain of Acute Otitis Media Treatment are Pfizer, Inc., Novartis AG, Eli Lilly and Company, Sanofi SA, Abbott Laboratories, Johnson and Johnson, Astrazeneca plc, GlaxoSmithKline plc, Bayer AG, Bristol Myers Squibb Company, Teva Pharmaceuticals, Takeda Pharmaceuticals and others
Sales Team
Client Partner
